US Oncology Debtholders Seek $40M From McKesson Tie-Up

Law360, New York (August 2, 2011, 5:57 PM EDT) -- Holders of $775 million in US Oncology Inc. debt told a New York state judge Tuesday that the cancer treatment service provider owes them $40 million more to redeem their debt securities following a merger with pharmaceutical distributor McKesson Corp.

The phrase "remaining term," which effects how an early-redemption premium is calculated, isn't clearly defined in the complex securities contract, Daniel A. Ross of Stroock & Stroock & Lavan LLP, an attorney for the debtholders, told New York Supreme Court Judge Bernard Fried.

"That's how people...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.